Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.8% Rally? GF Value Says Undervalued
On September 30, 2026, Hims & Hers Health Inc (HIMS) shares rose 3.8% today, currently trading at $29.79. The stock…
26,280€
3,87%
Echtzeit-Aktienkurs Hims & Hers Health
Bid:
Ask:
Nachrichten zur Hims & Hers Health Aktie
Hims & Hers: U.S. Revenue Reacceleration Is Reassuring, And Valuation Compression Is Compelling (Upgrade)
Hims & Hers Health is upgraded to Buy as growth reaccelerates and valuation compresses. Click to read my analysis for…
Hims Stock Reclaims $30 and Attempts Breakout but Faces $35 Test
Hims & Hers shares are attempting to recover above $30, but the rebound remains tentative as buyers challenge the 50-day…
Hims & Hers Health Rallies as Investors Appear to Reassess Recent Selloff
Hims & Hers Health (HIMS) is up 7.0% today. Here is some analysis on what might have caused this price…
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline
Hims & Hers Systems Shareholders Between August 4, 2025 and July 29, 2026 - Contact Bernstein Liebhard For More Information…
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline November 2, 2026...…
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Hims & Hers Health (HIMS) Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit...…
Hims & Hers upgraded to buy as revenue growth accelerates and valuation drops, signaling a strong entry point.
Hims & Hers has been upgraded to a buy rating due to its accelerating revenue growth and compressed valuation, making…
Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
What Do Todays Market Moves Mean for Hims & Hers Health (NYSE:HIMS)?
Hims & Hers Health (NYSE:HIMS) enters today’s market discussion as sector themes, operations, and broader conditions draw attention.…
INVESTOR ALERT: Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims &…
Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem
Key Stats for HIMS Stock52-Week Range: $14 to $65Market Cap: around $6. 9 billionStreet Mean Target: around $31Forward 2-Year Revenue…
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead…
HIMS consolidates near $29.56 resistance as weak momentum persists
Hims & Hers Health trades at $29.42 today, up 0.51%, as legal risk weighs on outlook and shares remain above…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock
Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock
Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock
Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims & Hers CFO Okupe sells $876,846 of HIMS stock
Hims & Hers CFO Okupe sells $876,846 of HIMS stock…
Hims And Hers Health (HIMS) Stock Looks Discounted After Its 368% Three Year Run
Hims & Hers Health has been a volatile ride, with long term shareholders seeing very large gains while more recent…
Hims & Hers Health (HIMS) Unveils AI Native Weight Loss Care Platform
Hims & Hers Health (NYSE:HIMS) introduced an AI native weight loss care platform built around a closed loop clinical system.…
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline November 2, 2026...…
Weekly Rundown: Abridge poised for broader VA expansion; Hims & Hers builds out AI-native care
Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief.…
Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Revenue Growth Might Change The Case For Investing In Hims & Hers Health Stock (HIMS)
Hims & Hers Health reported 38% revenue growth after acquiring Eucalyptus and raised full year guidance, while management flagged weaker…